CTR starts a new subsidiary – QAlliance AB – to support the Life Science industry with expertise and operational support within QA, quality assurance. The business will be led by Raf Lemmens, who has been appointed CEO of the company.
In recent years, Raf has worked consultatively with strategic quality questions at a number of growth companies, and has many years of experience in research, product development and production, clinical studies and business development within Life Science.
”Quality assurance is critical for the life science sector, and we look forward to supporting our present and new customers with sustainable quality work as well”, comments Karin Meyer, CEO of CTR. ”We welcome Raf to our team who, with his knowledge, enthusiasm and commitment, complements our company group in an excellent way”.
”I look forward to being part of the CTR family, and creating a company that offers QA services to Life Science customers”, says Raf Lemmens.
In this early phase of the QAlliance, the business will be built up by searching for and recruiting experienced QA Managers within GMP, GCP and GLP, while handling the first requests for quality partnerships.
Contact details
Raf Lemmens, raf.lemmens@qalliance.se +46 (0)70 747 31 30
Center for Translational Research Sweden (CTR)
CTR was founded 2016 and is a group of complementary life science service companies engaged in translational research. CTR is the owner of Clinical Trial Consultants, RegSmart Life Sciences, RegFile, Lablytica Life Science, Toxicology Knowledge Team Sweden, MetaSafe and QAlliance.